Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathways of allosteric regulation in Hsp70 chaperones.
Kityk R, Vogel M, Schlecht R, Bukau B, Mayer MP. Kityk R, et al. Among authors: vogel m. Nat Commun. 2015 Sep 18;6:8308. doi: 10.1038/ncomms9308. Nat Commun. 2015. PMID: 26383706 Free PMC article.
The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care.
Murthy V, Marvaso G, Jereczek-Fossa BA, Thoma SA, Vogel M, Schmidt-Hegemann NS, Shelan M, Siva S, Hoelscher T, Kishan AU, Peeken JC, Gillessen S, Guckenberger M, Herrmann K, Fendler WP, Zilli T, Spohn SKB, Zamboglou C. Murthy V, et al. Among authors: vogel m. Eur Urol. 2025 Jan 20:S0302-2838(25)00008-9. doi: 10.1016/j.eururo.2025.01.003. Online ahead of print. Eur Urol. 2025. PMID: 39837736
Epigenetics of childhood obesity.
Keller M, Vogel M, Garten A, Svensson SIA, Rossi E, Kovacs P, Böttcher Y, Kiess W. Keller M, et al. Among authors: vogel m. Horm Res Paediatr. 2025 Jan 14:1-24. doi: 10.1159/000543467. Online ahead of print. Horm Res Paediatr. 2025. PMID: 39809244 Free article. Review.
Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): results from a randomised, open-label, phase 3 trial.
Mina R, Mylin AK, Yokoyama H, Magen H, Alsdorf W, Minnema MC, Shune L, Isufi I, Harrison SJ, Shah UA, Schecter JM, Vogel M, Lendvai N, Gries KS, Katz EG, Slaughter A, Lonardi C, Gilbert J, Li Q, Deraedt W, Filho OC, Patel N, Florendo E, Karlin L, Weisel K. Mina R, et al. Among authors: vogel m. Lancet Haematol. 2025 Jan;12(1):e45-e56. doi: 10.1016/S2352-3026(24)00320-X. Lancet Haematol. 2025. PMID: 39756844 Clinical Trial.
2,239 results